亚宝药业：关于全资子公司取得药品注册证书的公告

Core Points - The company announced that its wholly-owned subsidiary, Beijing Yabao Biological Pharmaceutical Co., Ltd., has received the drug registration certificate for Sitagliptin Metformin Extended-Release Tablets from the National Medical Products Administration [1] Group 1 - The drug registration certificate has the number 2025S03027 [1]